{"id":"metronidazole-mtz","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Metallic taste"},{"rate":"5-10","effect":"Nausea"},{"rate":"3-5","effect":"Headache"},{"rate":"1-2","effect":"Peripheral neuropathy (with prolonged use)"},{"rate":null,"effect":"Disulfiram-like reaction with alcohol"},{"rate":"1-5","effect":"Darkening of urine"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is a prodrug that requires reduction by anaerobic organisms or parasites to form reactive intermediates that damage DNA and inhibit nucleic acid synthesis. It is effective against anaerobic bacteria and certain protozoan parasites, including Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia. The drug has been used clinically for decades and is a first-line treatment for anaerobic infections and parasitic diseases.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced inside microbial cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:21:05.163Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections"},{"name":"Trichomoniasis (Trichomonas vaginalis infection)"},{"name":"Amebiasis (Entamoeba histolytica infection)"},{"name":"Giardiasis (Giardia lamblia infection)"},{"name":"Bacterial vaginosis"},{"name":"Clostridioides difficile infection"}]},"trialDetails":[{"nctId":"NCT07086937","phase":"NA","title":"Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-01-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT06261840","phase":"PHASE4","title":"Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole","status":"RECRUITING","sponsor":"Tulane University","startDate":"2025-05-06","conditions":"Trichomonas Vaginitis, Bacterial Vaginitis","enrollment":1200},{"nctId":"NCT03329092","phase":"PHASE3","title":"A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-04-05","conditions":"Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia","enrollment":422},{"nctId":"NCT05444218","phase":"NA","title":"Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2021-05-01","conditions":"Peri-Implantitis","enrollment":89},{"nctId":"NCT03580044","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria","status":"TERMINATED","sponsor":"Pfizer","startDate":"2020-12-25","conditions":"Serious Bacterial Infection","enrollment":15},{"nctId":"NCT04189744","phase":"PHASE3","title":"The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-12-15","conditions":"Pregnancy Malaria, Bacterial Vaginoses, Trichomonas Vaginitis","enrollment":5436},{"nctId":"NCT05115201","phase":"NA","title":"Effect of Antibiotics on Systemic Inflammation","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2021-11-26","conditions":"Periodontitis","enrollment":41},{"nctId":"NCT02954393","phase":"NA","title":"Amoxicillin and Metronidazole During Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2015-05","conditions":"Chronic Periodontitis","enrollment":180},{"nctId":"NCT02735395","phase":"PHASE4","title":"Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis","enrollment":110},{"nctId":"NCT01832480","phase":"PHASE3","title":"Trichomonas Vaginalis Repeat Infections Among HIV Negative Women","status":"COMPLETED","sponsor":"Tulane University Health Sciences Center","startDate":"2014-10-06","conditions":"Vaginitis Trichomonal or Due to Trichomonas","enrollment":623},{"nctId":"NCT00752219","phase":"PHASE2","title":"Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-03-31","conditions":"Complicated Intra-abdominal Infections","enrollment":204},{"nctId":"NCT03169946","phase":"NA","title":"Chlorhexidine-Metronidazole Combination as an Intracanal Medicament on Periodontal Healing","status":"UNKNOWN","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2016-10-14","conditions":"Periodontal and Endodontic Lesion","enrollment":36},{"nctId":"NCT02422706","phase":"PHASE3","title":"Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori","status":"UNKNOWN","sponsor":"Sherief Abd-Elsalam","startDate":"2015-01","conditions":"Helicobacter-associated Gastritis","enrollment":120},{"nctId":"NCT02365389","phase":"PHASE2, PHASE3","title":"Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2014-05","conditions":"Vaginitis","enrollment":64},{"nctId":"NCT02135952","phase":"PHASE4","title":"Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-09","conditions":"Periodontitis","enrollment":58},{"nctId":"NCT01938183","phase":"PHASE2","title":"Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2006-11","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT01837199","phase":"PHASE4","title":"MTZ Plus AMX in the Treatment of Smokers and Non-smokers","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis, Smoking","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Flagyl"],"phase":"phase_3","status":"active","brandName":"Metronidazole(MTZ)","genericName":"Metronidazole(MTZ)","companyName":"Sherief Abd-Elsalam","companyId":"sherief-abd-elsalam","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced inside microbial cells. Used for Anaerobic bacterial infections, Trichomoniasis (Trichomonas vaginalis infection), Amebiasis (Entamoeba histolytica infection).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}